300+ investors in your industry, stage, and region Get
Any industry
Google
Biotech
Proptech
Climate
Artificial Intelligence
Impact
EdTech
Sustainability
Clean Energy
Retail
Finance
Digital Media
Local
Travel
Enterprise Software
Platforms
Recruiting
Social
Wine and Spirits
Mobile Apps
InsurTech
Oil and Gas
Theatre
Non Profit
Celebrity
Social Impact
Cryptocurrency
SaaS
Film
Crowdfunding
Venture Capital
Infrastructure
Restaurants
Sporting Goods
Fashion
LGBT
Photography
Payments
Renewable Energy
Organic Food
Email
Financial Services
Manufacturing
Fitness
CleanTech
Energy
Health Care
Agriculture (AgTech)
Machine Learning
Marketplace
Community
Hardware
Gaming
Media (Entertainment)
Facebook
Beauty
Blockchain
Publishing
Food and Beverage
Social Network
Web3
Big Data
Video Games
Education
Medical
Wellness
Medical Device
Art
Social Media
Android
Internet
Franchise
Music
Mobile
Legal
Construction
Automotive
Sports
eSports
Hospitality
Cannabis
Mobile Advertising
Biotechnology
FinTech
Consumer
Transportation
Real Estate
Life Science
Enterprise
Software
B2B
Any country
South Korea
Oceania
Asia
Brazil
Africa
Middle East
Europe
LATAM
Saudi Arabia
Singapore
Finland
Gibraltar
Greece
Norway
Israel
Tajikistan
Taiwan
Zimbabwe
Puerto Rico
Russian Federation
Sweden
San Marino
Togo
Tunisia
Zambia
Nigeria
Italy
Isle of Man
Mongolia
Pakistan
Lebanon
Romania
Liberia
Mexico
Cameroon
Oman
Colombia
Australia
India
New Zealand
China
Indonesia
Sri Lanka
Vietnam
Armenia
Austria
Barbados
Albania
Bangladesh
Belgium
Argentina
Bahrain
Costa Rica
Belarus
Belize
Chile
Switzerland
Czech Republic
Estonia
Algeria
Honduras
Iceland
Cambodia
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Slovenia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Japan
Seychelles
Germany
Canada
United Kingdom
Ireland
Cyprus
Qatar
Spain
South Africa
United Arab Emirates
Azerbaijan
Bulgaria
Bolivia
Bermuda
Bahamas
Egypt
France
Georgia
Faroe Islands
Denmark
Dominican Republic
Ecuador
Croatia
Hong Kong
Ghana
Ethiopia
Grenada
Iraq
Hungary
Jordan
Jersey
Liechtenstein
Mali
Myanmar
Latvia
Morocco
Lithuania
Malaysia
Peru
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Thailand
El Salvador
Senegal
Tanzania
Uruguay
Ukraine
United States
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech VC Funds & Investors in Israel (June 2026)

The most active venture capital funds investing in Israel Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Israel Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Trendlines Group
VC Fund
17 Israel, Singapore, United Kingdom Seed, Series A Health Care, Biotechnology, Medical Device $650k–$15M
Pontifax
VC Fund
16 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical $4M–$104M
Israel Innovation Authority
VC Fund
12 Israel, United States, Mali Grant, Seed, Pre-Seed Health Care, Biotechnology, Medical Device $100k–$6M
OurCrowd
VC Fund
10 Israel, United States, New Zealand Series B, Series A, Seed Software, Artificial Intelligence, Health Care $612k–$70M
OrbiMed
VC Fund
7 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $10M–$150M
aMoon Fund
VC Fund
7 United States, Israel, France Series B, Series A, Series C Health Care, Biotechnology, Medical $5.7M–$93M
Arkin Holdings
VC Fund
6 Israel, United States, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Medical $2M–$95M
Docor International Management
VC Fund
6 Israel, United States Series C, Series A Health Care, Biotechnology, 3D Technology $13M–$22M
HBL Hadasit Bio Holdings
VC Fund
5 Israel Series A, Series B Biotechnology, Medical, Health Care
ZORA Ventures
VC Fund
5 Israel, United States, United Kingdom Seed, Series A, Convertible Note Health Care, Biotechnology, Internet $1M–$7M
Grove Ventures
VC Fund
4 Israel, United States Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $3.5M–$74M
Takeda Ventures
VC Fund
4 United States, United Kingdom, Israel Series A, Series B Biotechnology, Health Care, Therapeutics $10M–$130M
Johnson & Johnson Robotics and Digital Solutions
VC Fund
4 United States, Israel, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $300k–$100M
Integra Holdings
VC Fund
4 Israel Seed, Series B, Series F Biotechnology, Pharmaceutical, Life Science
iAngels
VC Fund
4 United States, Israel, United Kingdom Seed, Series A Software, Artificial Intelligence, Financial Services $1M–$22M
Clal Biotechnology Industries
VC Fund
4 Israel, United States Series A, Series B Health Care, Biotechnology, Medical $4M–$55M
Sapir Venture Partners
VC Fund
4 Israel, United States, United Kingdom Seed, Pre-Seed, Series A Software, Biotechnology, Machine Learning $1.3M–$40M
New York Ventures
VC Fund
4 United States, Canada, Israel Seed, Series A, Series B Health Care, Biotechnology, Software $1.5M–$53M
SciSparc
VC Fund
3 Israel Corporate Round Pharmaceutical, Cannabis, Biopharma $400k–$700k
Welltech Ventures
VC Fund
3 Israel, United States Seed, Pre-Seed mHealth, Health Care, Biotechnology $1.9M–$19M
Binder & Partners Ventures
VC Fund
3 Israel, France, United States Seed, Pre-Seed, Series A Software, Information Technology, Computer $8M–$14M
FutuRx
VC Fund
3 Israel Seed Biotechnology, Life Science, Biopharma
Ziegler Meditech Equity Partners
VC Fund
3 United States, Israel Series C, Series E, Series F Health Care, Biotechnology, Mobile
Milk & Honey Ventures
VC Fund
3 Israel Pre-Seed, Seed, Series A Biotechnology, Food and Beverage, Nutrition $1.8M–$1.9M
Nevateam Partners
VC Fund
3 Israel Seed, Series A AgTech, SaaS, Farming $5M–$10M
Siddhi Capital
VC Fund
3 United States, Israel, Canada Seed, Series A, Series B Food and Beverage, Biotechnology, Nutrition $1.7M–$106M
Cancer Focus Fund
VC Fund
3 Israel, United States, Germany Series A, Seed Biotechnology, Medical, Health Care $5.4M–$28M
Pitango VC
VC Fund
3 Israel, United States, China Series A, Series B, Series C Software, Health Care, Information Technology $4M–$100M
Millenium Food-Tech
VC Fund
3 Israel Seed, Series A, Convertible Note Food and Beverage, Manufacturing, Retail $2.5M–$15M
Accelmed
VC Fund
3 Israel, United States Series D, Series A Health Care, Medical Device, Medical $695k–$96M
EIT Food
VC Fund
3 United Kingdom, Israel, Germany Grant, Seed Food and Beverage, Biotechnology, Food Processing $30k–$11M
fresh.fund
VC Fund
3 Israel, United States, Norway Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $120k–$21M
Office of the Chief Scientist
VC Fund
3 Israel Seed Health Care, Biotechnology, Hardware $500k–$1M
Consensus Business Group
VC Fund
3 Israel, United States, United Kingdom Seed, Series A Health Care, Medical Device, Medical $1M–$10M
GlenRock Israel
VC Fund
3 Israel, United States Seed, Series B, Series A Software, Cyber Security, Health Care $100k–$19M
The Food Tech Lab
VC Fund
2 Israel, Spain, Sweden Seed, Pre-Seed Biotechnology, Manufacturing, Food and Beverage
The Chartered Group
VC Fund
2 Israel Series A, Private Equity Biopharma, Agriculture, Health Care
MoreVC
VC Fund
2 Israel, United States, Canada Series A, Seed Software, Energy, Renewable Energy
Agriline
VC Fund
2 Israel Seed, Series A Health Care, Medical Device, Medical
SOSV
VC Fund
2 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
ALIVE Israel HealthTech Fund
VC Fund
2 Israel, United States Series A, Series B Health Care, Medical, Biotechnology
NextLeap Ventures
VC Fund
2 Israel, United States Seed, Series A Software, Machine Learning, Health Care
Elron Ventures
VC Fund
2 Israel, United States, China Seed, Series A Information Technology, Health Care, Software
Chartered Opus
VC Fund
2 Israel Series A Wellness, Biotechnology, Manufacturing
Yozma Group
VC Fund
2 Israel, United States, Australia Series B, Seed Health Care, Medical, Software
VentureIsrael
VC Fund
2 Israel Seed, Pre-Seed, Series A Information Technology, Software, Cyber Security
Triventures
VC Fund
2 United States, Israel, Ireland Series A, Series B Health Care, Medical Device, Medical
Fortissimo Capital
VC Fund
2 Israel, United States, Italy Series B, Series C Manufacturing, Software, Information Technology
NFX
VC Fund
2 United States, Israel, United Kingdom Seed, Series A, Pre-Seed Software, Information Technology, Marketplace
BRM Capital
VC Fund
2 United States, Israel Series B, Series A Software, Information Technology, Internet
Access all 50 VC funds in Israel Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Trendlines Group
VC Fund · Misgav, HaZafon, Israel · 17 investments in Israel Biotech startups

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A
  • Geography: Israel, Singapore, United Kingdom

Investor stats

  • Total investments: 67
  • Round size: Seed $650k–$3.2M; Series A $2.3M–$15M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
  • Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
  • Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 16 investments in Israel Biotech startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 106
  • Round size: Series A $4M–$95M; Series B $20M–$100M; Series C $12M–$104M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2020

Portfolio highlights

  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
  • Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Show all investments...

Israel Innovation Authority
VC Fund · Jerusalem, Yerushalayim, Israel · 12 investments in Israel Biotech startups, 9 in the past 12 months

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Israel, United States, Mali

Investor stats

  • Total investments: 141
  • Round size: Seed $590k–$6M; Grant $100k–$3.5M; Pre-Seed $150k–$2.5M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Q-Factor
  • Sub-Q Bionics — Sub-Q Bionics is a medtech company, that aids the management of chronic pain and debilitating symptoms of lymphedema specially for women.
  • Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Show all investments...

OurCrowd
VC Fund · Jerusalem, Yerushalayim, Israel · 10 investments in Israel Biotech startups

Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series B, Series A, Seed
  • Geography: Israel, United States, New Zealand

Investor stats

  • Total investments: 261
  • Round size: Seed $612k–$8M; Series A $5.3M–$22M; Series B $8M–$70M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Corgi Insurance — Corgi Insurance Services, Inc. ("Corgi") is an American technology company that operates an artificial intelligence (AI)-powered insurance carrier based in San Francisco, California. Corgi Insurance develops and operates a fully integrated insurance stack using AI agents to automate traditional carrier operations, becoming the world’sfirst “AI insurance company.” The company owns multiple subsidiaries operating under a dog-themed naming convention.
  • PhenOlives — PhenOlives transforms olive oil waste into nutritious, gluten-free olive flour that retains the health benefits of olive oil. The company employs a patented process to create a high-fiber ingredient suitable for various baking and cooking applications.
  • BetterSeeds — The company focuses on non-GMO genome editing using CRISPR-Cas9 for creating a novel breed of seeds and crop traits that address the 21st-century agriculture challenges. BetterSeeds provides advanced seeds enabling better crops for mechanized harvesting, extreme e climate resistance, higher calory and nutrient values, and more.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 7 investments in Israel Biotech startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 576
  • Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$131M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • resTORbio — Restore Beauty - Rethink Bio
  • Caris Life Sciences — Caris fulfills the promise of precision oncology through advanced laboratory testing, including tumor profiling and blood-based cancer diagnostics.
Show all investments...

aMoon Fund
VC Fund · Ra'anana, HaMerkaz, Israel · 7 investments in Israel Biotech startups, 6 in the past 12 months

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 75
  • Round size: Series A $5.7M–$83M; Series B $22M–$93M; Series C $30M–$82M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
  • Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Show all investments...

Arkin Holdings
VC Fund · Herzliya, Tel Aviv, Israel · 6 investments in Israel Biotech startups

Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: Israel, United States, Switzerland

Investor stats

  • Total investments: 31
  • Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $270M in 2021

Portfolio highlights

  • Lendbuzz — Lendbuzz is an AI-based auto finance platform that helps consumers with thin or no credit history obtain financing when purchasing a car. Powered by machine learning and proprietary algorithms, Lendbuzz is able to better assess the creditworthiness of consumers with limited credit history, who are underserved by the traditional banks. By partneringwith auto dealerships, Lendbuzz is able to offer consumers attractive financing solutions and dealerships are able to close additional business opportunities and serve a more diversified client base. Lendbuzz is headquartered in Boston, Massachusetts and was founded in 2015.
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
Show all investments...

Docor International Management
VC Fund · Tel Aviv, Tel Aviv, Israel · 6 investments in Israel Biotech startups

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, 3D Technology
  • Stage:Series C, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 14
  • Round size: Series C $13M–$22M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Check-Cap — Check-Cap Ltd. is merging with MBody AI to create a leading publicly traded embodied AI company powering autonomous workforces.
  • Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
  • Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Show all investments...

HBL Hadasit Bio Holdings
VC Fund · Jerusalem, Yerushalayim, Israel · 5 investments in Israel Biotech startups

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B
  • Geography: Israel

Investor stats

  • Total investments: 9
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Show all investments...

ZORA Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 5 investments in Israel Biotech startups

Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Internet
  • Stage:Seed, Series A, Convertible Note
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 13
  • Round size: Seed $1M–$7M; Series A $4M–$6M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • BiotaX — Microbiome Genomic Analysis Cloud Platform | Biotax.co
  • Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
  • Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Grove Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Israel Biotech startups, 6 in the past 12 months

Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 68
  • Round size: Seed $3.5M–$20M; Series A $8M–$50M; Series B $20M–$74M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $185M in 2022

Portfolio highlights

  • Niv-AI — Niv-AI develops an AI platform that optimizes power usage in AI data centers by capturing real-time electricity consumption data and dynamically balancing workloads. It addresses bottlenecks where synchronized GPUs create sharp power spikes, unlocking up to 30% of stranded capacity without new hardware.
  • NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
  • Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Show all investments...

Takeda Ventures
VC Fund · San Diego, California, United States · 4 investments in Israel Biotech startups

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 103
  • Round size: Series A $10M–$58M; Series B $20M–$130M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
  • Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
  • Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Show all investments...

Johnson & Johnson Robotics and Digital Solutions
VC Fund · New Brunswick, New Jersey, United States · 4 investments in Israel Biotech startups

Healthcare innovation wherever it originates.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 70
  • Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
  • Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
  • ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.
Show all investments...

Integra Holdings
VC Fund · Wallisellen, Zurich, Switzerland · 4 investments in Israel Biotech startups

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Life Science
  • Stage:Seed, Series B, Series F
  • Geography: Israel

Investor stats

  • Total investments: 8
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
  • Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
  • Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Show all investments...

iAngels
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Israel Biotech startups

Invest in groundbreaking startups with iAngels. Discovercutting-edge technology and join a community of forward-thinking investors shapingthe future of entrepreneurship.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Financial Services
  • Stage:Seed, Series A
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 120
  • Round size: Seed $1M–$10M; Series A $4.5M–$22M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: Likely still investing — raised $56M in 2021

Portfolio highlights

  • Nas Daily
  • Wild Moose — Wild Moose helps on-call developers more quickly identify the source of production incidents, by providing a conversational AI trained on their environment. This allows developers to delegate the search through logs and metrics to lightning-fast AI.
  • Lava Network — Lava Network aims to be a marketplace for blockchain data.
Show all investments...

Clal Biotechnology Industries
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Israel Biotech startups

Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 14
  • Round size: Series A $4M–$55M; Series B $15M–$33M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
  • Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
  • Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
Show all investments...

Sapir Venture Partners
VC Fund · 4 investments in Israel Biotech startups

Early Stage VC

Show more...

Investment focus

  • Industry: Software, Biotechnology, Machine Learning
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 20
  • Round size: Seed $1.3M–$5M; Series A $10M–$40M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
  • Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
  • DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
Show all investments...

New York Ventures
VC Fund · New York, New York, United States · 4 investments in Israel Biotech startups

New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the RegionalEconomic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 118
  • Round size: Seed $1.5M–$7M; Series A $3M–$20M; Series B $2.5M–$53M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Fathom Therapeutics — Fathom Therapeutics, previously known as Atommap, is a biotechnology company focused on designing therapeutic molecules through computational drug discovery approaches. The company develops models that simulate biomolecular and protein motion to better understand how proteins behave and interact, enabling the identification of new therapeuticstrategies. Its platform combines generative design, predictive modeling, and computational assays to create and evaluate molecular candidates for their binding affinity and functional effects. By leveraging these simulations, it supports drug discovery processes such as hit identification, lead optimization, and the design of targeted molecules, including degraders and molecular glues. The company also collaborates with partners by providing molecular designs, predictive insights, and co-development opportunities for advancing therapeutic candidates.
  • Adro — Designed to work when you arrive Spend and save like a local. Easy to use. No unfair fees.
  • CREW Carbon — CREW provides wastewater treatment facilities with a process intensification solution that improves performance, lowers costs, and permanently removes greenhouse gasses.
Show all investments...

SciSparc
VC Fund · Giv'atayim, Tel Aviv, Israel · 3 investments in Israel Biotech startups

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.

Show more...

Investment focus

  • Industry: Pharmaceutical, Cannabis, Biopharma
  • Stage:Corporate Round
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Round size: Corporate Round $400k–$700k
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • LaraPharm — LaraPharm Ltd. is a group of people joined together by the belief that active components found in the Cannabis plant can provide a real answer to hundreds of types of disease currently not addressed at all, or poorly addressed.
  • MitoCareX Bio — MitoCareX Bio is a biotechnology company that focuses on the discovery and development of drugs for cancers & other life-threatening diseases.
Show all investments...

Welltech Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Biotech startups

Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.

Show more...

Investment focus

  • Industry: mHealth, Health Care, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Israel, United States

Investor stats

  • Total investments: 11
  • Round size: Seed $1.9M–$19M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Antidote Health — AntidoteHealth.ai offers primary care on its telehealth app on a 24/7 basis, including prescriptions & more. Book your appointment today!
  • Behavidence — Behavidence is a mental health application that generates a daily mental health score. It compares your digital behavior to other people with anxiety, depression and ADHD.
  • Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Binder & Partners Ventures
VC Fund · Paris, Ile-de-France, France · 3 investments in Israel Biotech startups

Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.

Show more...

Investment focus

  • Industry: Software, Information Technology, Computer
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, France, United States

Investor stats

  • Total investments: 14
  • Round size: Series A $8M–$14M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Rookout — Code doesn’t always behave as you expect it to and your team is wasting too much time to understand why. Rookout provides secure, fast, and simple data access, no matter what architecture or where the code is running. By providing the developer with instant, laser-focused data, developer teams can understand their code and see an increase inproductivity, velocity, and efficiency.
  • Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
  • Blink Technologies — Blink Technologies is developing a robust, non-intrusive passive, eye-tracking technology without the need for special dedicated hardware. Their non-invasive, AI-based Software Solution can be deployed with any Camera technology on the market today. The proprietary solution integrates with any OS and can run locally (edge-based) or remotely(cloud-based).Blink Technologies was founded in 2018 and is based in Palo Alto, California, United States.
Show all investments...

FutuRx
VC Fund · Ness Ziona, HaMerkaz, Israel · 3 investments in Israel Biotech startups

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

Show more...

Investment focus

  • Industry: Biotechnology, Life Science, Biopharma
  • Stage:Seed
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
  • Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
  • Bsense Bio Therapeutics — Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders. Bsense pioneers a novel approach targeting multiple hyperexcitability-related mechanisms using a single compound, to achieve greater efficacy and safety.
Show all investments...

Ziegler Meditech Equity Partners
VC Fund · Milwaukee, Wisconsin, United States · 3 investments in Israel Biotech startups

Ziegler is a privately held investment bank, capital markets and proprietary investments firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Mobile
  • Stage:Series C, Series E, Series F
  • Geography: United States, Israel

Investor stats

  • Total investments: 6
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
  • MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
  • MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
Show all investments...

Milk & Honey Ventures
VC Fund · 3 investments in Israel Biotech startups

Tel-Aviv based investment firm, focused on the effective acceleration of disruptive New Protein technologies

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Nutrition
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Israel

Investor stats

  • Total investments: 4
  • Round size: Pre-Seed $1.8M–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
  • SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
  • Meala Foodtech — Revolutionary texturized plant proteins that replace eggs and hydrocolloids. Clean-label, allergen-free solutions for baking, savory foods, and dressings.
Show all investments...

Nevateam Partners
VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in Israel Biotech startups

NevaTeam Partners is an Agri-Food Tech ESG Impact driven Fund with world-class knowledge and expertise that specializes in identifying and investing in cutting-edge companies and technologies, contributing to the streamlining and increase in world food production in a sustainable way.

Show more...

Investment focus

  • Industry: AgTech, SaaS, Farming
  • Stage:Seed, Series A
  • Geography: Israel

Investor stats

  • Total investments: 5
  • Round size: Seed $5M–$10M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
  • Clarifruit — First automated fruit and vegetable fresh produce quality control software solution by Clarifresh. Optimize your fresh produce QC >>
  • Edete Precision Technologies for Agriculture — edete Precision Agriculture Technologies is solving the world’s ever-growing pollination challenge by developing and manufacturing an efficient, automated fruit orchard pollination system and providing optimized pollination services to companies and growers.By reducing the dependency on haphazard, insect-based pollination processes, edete’scontrolled and manageable mechanical pollination system improves the quantity and quality of fruit orchard yields.
Show all investments...

Siddhi Capital
VC Fund · Cherry Hill, New Jersey, United States · 3 investments in Israel Biotech startups

Siddhi Capital is the growth equity partner for convention-crushing food and beverage companies.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Nutrition
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 55
  • Round size: Seed $1.7M–$6.3M; Series A $5M–$21M; Series B $10M–$106M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Exosomm — Exosomm is an advanced BioTech-FoodTech startup, located in Israel, that created a food formula for medical purposes, containing patent-based milk exosomes for patients with inflammatory bowel diseases (IBD).
  • BlueNalu — BlueNalu's mission is to be the global leader in cellular aquaculture, providing consumers with great tasting, healthy, safe, and trusted seafood products that support the sustainability and diversity of our oceans.
  • Liberation Bioindustries — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
Show all investments...

Cancer Focus Fund
VC Fund · Shreveport, Louisiana, United States · 3 investments in Israel Biotech startups

Cancer Focus Fund is an oncology-focused investment firm advancing breakthrough cancer therapies by partnering with leading scientists, institutions and early-stage companies.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Seed
  • Geography: Israel, United States, Germany

Investor stats

  • Total investments: 10
  • Round size: Series A $5.4M–$28M
  • Lead/follow: 60% lead, 40% follow
  • Last fund: May invest from a new fund soon — raised $50M in 2019

Portfolio highlights

  • March Biosciences — Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity of
  • Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
  • Nectin Therapeutics — NectinTX develops next-generation delivery platforms for immuno-oncology and precision therapeutics. Discover breakthrough protein expression technologies that power safer, more effective treatments.
Show all investments...

Pitango VC
VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in Israel Biotech startups

Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: Israel, United States, China

Investor stats

  • Total investments: 277
  • Round size: Series A $4M–$47M; Series B $7.5M–$44M; Series C $8.2M–$100M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $175M in 2023

Portfolio highlights

  • Nexite — Nexite develops a platform that provides item tracking, inventory transparency and business intelligence from manufacturing to the customer's home. Its miniature NanoBT batteryless tag can be read by any smartphone, costs a fraction of the cost of similar tags, and is small enough to embed into the item. The company was founded in 2017 andis headquartered in Tel Aviv, Israel.
  • Sayata — Sayata delivers rapid growth to brokers and carriers that place commercial risk.The Sayata platform streamlines the quote-bind-issue process allowing insurance professionals to seamlessly place commercial risk in a fraction of the time.Sayata provides an end-to-end technological solution along with educational tools, giving our partners theability to grow their book quickly and efficiently.To date, over 1,000 users across 75 brokerages and carriers partner with Sayata to grow their commercial book.
  • Topspin Medical — TopSpin Medical developed an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI setup. The catheter contains those components, which are usually found in a conventional MRI scanner, only that they are miniaturizedto less than 2 millimeters in size.
Show all investments...

Millenium Food-Tech
VC Fund · 3 investments in Israel Biotech startups

Millennium Food-Tech is an R&D partnership traded on the Tel Aviv Stock Exchange that specializes in investment in and betterment of companies in food-tech sectors,. Millennium seeks to invest in companies that specialize in identifying and developing innovative, and transformative ideas in the food, drinks, and nutrition industry. Millenniumhas experienced management, proven solutions, and a supportive network to develop ideas and start-ups from early-stage to maturity to exit.

Show more...

Investment focus

  • Industry: Food and Beverage, Manufacturing, Retail
  • Stage:Seed, Series A, Convertible Note
  • Geography: Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $2.5M–$4.1M; Series A $3.5M–$15M; Convertible Note $4M–$10M
  • Lead/follow: 73% lead, 27% follow

Portfolio highlights

  • ansā — Objectively Awesome Coffee
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Supersmart — Supersmart is the world's leading loss-prevention solution for self-scan transactions. Supersmart uses its proprietary machine-learning, AI algorithm to validate all self-scanning transactions in physical stores. Our solution enables retailers to confidently provide self-scanning options to their customers, enhancing customer experiencewithout sacrificing potential loss.The Israel-based company was founded in 2014 by Yair Cleper and Amir Ayalon.
Show all investments...

Accelmed
VC Fund · Aventura, Florida, United States · 3 investments in Israel Biotech startups

Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series D, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 36
  • Round size: Series A $695k–$24M; Series D $13M–$96M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • NeuroPace — The NeuroPace RNS System is the only FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity and provides EEG data that can help improve patient care.
  • UltraClear
  • GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
EIT Food
VC Fund · Belgium, Wisconsin, United States · 3 investments in Israel Biotech startups

EIT Food is a European Knowledge and Innovation Community (KIC), which was set up to transform our food ecosystem. By connecting consumers with businesses, start-ups, researchers and students from around Europe, EIT Food supports innovative and economically sustainable initiatives which improve our health, our access to quality food, and our environment

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Food Processing
  • Stage:Grant, Seed
  • Geography: United Kingdom, Israel, Germany

Investor stats

  • Total investments: 86
  • Round size: Seed $226k–$11M; Grant $30k–$572k
  • Lead/follow: 63% lead, 37% follow

Portfolio highlights

  • BettaF!sh — BettaF!sh is the first company developing 100% plant-based tuna alternatives mainly created with seaweed from Europe.
  • Hooked Foods — Leading the transition to a harmless seafood system by serving healthy vegan seafood for everybody to truly enjoy.
  • New Wave Biotech — New Wave Biotech's AI Downstream Process Optimization Software empowering SynBio innovators to get to market quicker, better and at lower cost. By simulating bioprocesses, techno economic analysis and auto optimisation, we help precision fermented alternative protein and other industrial biotechnology products improve yield and scale production.
Show all investments...

fresh.fund
VC Fund · Jerusalem, Yerushalayim, Israel · 3 investments in Israel Biotech startups

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, Norway

Investor stats

  • Total investments: 41
  • Round size: Seed $3M–$12M; Pre-Seed $120k–$6M; Series A $11M–$21M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Wisio — Wisio lets social media creators and experts answer questions and requests from followers via paid interactions. The company’s platform empowers followers to gain exclusive access via personalized videos to their favorite creators. Wisio's flexible and easy-to-use platform is packed with features to help creators build deeper communitieswhile monetizing the creator - follower relationship. Thousands of them are already using it to help build their online reputation and business.Wisio's vision is to make everyone reachable.
  • Clearitty — Clearitty - The Ultimate Sales Accelerator by Turning Deal Insights into Revenue We provide the tools and insights for sales executives to close deals faster and outperform competitors, empowering you to drive growth and success. It’s free to start — no trial, no contract, no risk.Clearitty was born out of a shared frustration experienced bysales executives and entrepreneurs alike – the lack of critical insights about new buyers. These invaluable insights are often held by those who have successfully navigated the sales process with these coveted clients.Recognizing the gap, in 2022 we created Clearitty, dedicated to developing an intelligence tool that helps sales executives shorten sales cycles and close deals more efficiently.Our goal is to build the world’s largest database of buyer insights, empowering sales executives with the knowledge they need to succeed.
  • Sherloq — Ask your SQL anything. Built on your context, directly on your editor.
Show all investments...

Office of the Chief Scientist
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Biotech startups

The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Hardware
  • Stage:Seed
  • Geography: Israel

Investor stats

  • Total investments: 4
  • Round size: Seed $500k–$1M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
  • Sqwik - powered by Geev.Me.Tech LTD — Sqwik is a new way to create, join & follow fun activities, with new friends, within 3 hours.
  • Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
Show all investments...

Consensus Business Group
VC Fund · London, England, United Kingdom · 3 investments in Israel Biotech startups

Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed, Series A
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 21
  • Round size: Seed $1.7M–$4.1M; Series A $1M–$10M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
  • MEDX Xelerator — MEDX Xelerator is a unique medical device and digital health incubator. It was founded by MEDX Ventures Group, together with three partners: Boston Scientific, Intellectual Ventures’ Invention Science Fund and Sheba Medical Center. Each of MEDX Xelerator’s partners contributes outstanding core competencies, which complement one another and togethercreate a solid foundation for your success. Our incubator is seeking medical innovations for minimally invasive procedures, medical robotics, medical implants and digital health.Our vision is to leverage the power of MEDX Xelerator, and together with the extraordinary Israeli med tech innovation scene create a local cluster of entrepreneurial companies with breakthrough solutions to true unmet medical needs. Our mission is to nurture those promising technologies into successful medical ventures for the benefit of patients and health care professionals. We see you, the entrepreneur, as the key to success and we are here for you to make it happen.
  • Synchrony Medical — Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment.
Show all investments...

GlenRock Israel
VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in Israel Biotech startups

A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.

Show more...

Investment focus

  • Industry: Software, Cyber Security, Health Care
  • Stage:Seed, Series B, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 32
  • Round size: Seed $1M–$19M; Series A $1.5M–$9M; Series B $100k–$12M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
  • MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
  • Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
Show all investments...

The Food Tech Lab
VC Fund · Spain, Georgia, United States · 2 investments in Israel Biotech startups

The Food Tech Lab (TFTL), is an investment club formed by a network of investors, mostly professionals linked to the agri-food sector.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Food and Beverage
  • Stage:Seed, Pre-Seed
  • Geography: Israel, Spain, Sweden

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Brevel — Brevel is leading the way with its breakthrough fermentation technology, offering delicious, affordable and sustainable protein.
  • Pack2Earth — Pack2Earth, S.L. is a company that specializes in developing new, sustainable materials for the food sector and other industries.
  • BlueRedGold — Discover BlueRedGold - the home of exquisite Swedish Saffron, ethically grown and harvested with precision in Sweden. Experience the unparalleled quality of our saffron, perfect for culinary enthusiasts and chefs alike. Join us in embracing sustainable luxury.
Show all investments...

The Chartered Group
VC Fund · 2 investments in Israel Biotech startups

The Chartered Group is an investment platform.

Show more...

Investment focus

  • Industry: Biopharma, Agriculture, Health Care
  • Stage:Series A, Private Equity
  • Geography: Israel

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Zsquare — Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use.
  • Pepticom Ltd. — Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators.
Show all investments...

MoreVC
VC Fund · Ra'anana, HaMerkaz, Israel · 2 investments in Israel Biotech startups

MoreVC invests in seed and early stage Israeli technology start-ups, partnering with entrepreneurs who are building companies that matter.

Show more...

Investment focus

  • Industry: Software, Energy, Renewable Energy
  • Stage:Series A, Seed
  • Geography: Israel, United States, Canada

Investor stats

  • Total investments: 60
  • Lead/follow: no public data

Portfolio highlights

  • Gavan — Transforming the way proteins are delivered. Our technology extracts high purity proteins from source while maintaining their physical structure unharmed and preserving their high functionality.
  • Ubeya — Ubeya is an employee management platform that helps manage shift and hourly employees. Offering an and-to-end solution for Staffing Agencies, Catering and Hospitality industries, Delivery Fleets, and more. Helping Managers, Payroll, HR and Legal departments to digitize operations with an employee app and a client portal. Our modular system allows each business to choose the functions that best serve their business: Schedule, Clock-in, Track, Communicate and Pay your employees with Ubeya.
  • Quinn — hyve is your new favorite money app that uses the power of your people to help you save, invest, and get out of debt way faster! Download the app today.
Show all investments...

Agriline
VC Fund · Bromsgrove, Worcestershire, United Kingdom · 2 investments in Israel Biotech startups

Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed, Series A
  • Geography: Israel

Investor stats

  • Total investments: 15
  • Lead/follow: no public data

Portfolio highlights

  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
  • SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 2 investments in Israel Biotech startups, 95 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1465
  • Lead/follow: no public data

Portfolio highlights

  • NovoNutrients — NovoNutrients is working to turn waste CO2 into high-value, low-cost proteins and additives for food and feed by developing proprietary microbes and advanced gas fermentation systems.
  • OncoPrecision — We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity and Resistance Test, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access toPrecision Oncology and improve cancer patients' lives.
  • Sodex Innovations — Sodex Innovations is a company which is specialized in developing assistance-systems and automating-kits for excavators
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
ALIVE Israel HealthTech Fund
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Biotech startups

ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 12
  • Lead/follow: no public data

Portfolio highlights

  • Wisdo Health — Wisdo is an AI-powered Social Health platform harnessing the power of data and meaningful connections to improve health.
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
  • Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Show all investments...

NextLeap Ventures
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Biotech startups

NextLeap Ventures offers investors the opportunity to invest in early stage, Israeli high-tech startups, selected through its unique, highly vetted process.

Show more...

Investment focus

  • Industry: Software, Machine Learning, Health Care
  • Stage:Seed, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 15
  • Lead/follow: no public data

Portfolio highlights

  • Carrar — A complete thermal management solution for electric vehicles dissipating heat faster and more efficiently than ever before. Thermal management for ev batteries.
  • Cybord — Electronics components' quality, reliability, and highest level of traceability by leveraging visual AI and BigData
  • Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
Show all investments...

Elron Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Biotech startups

Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.

Show more...

Investment focus

  • Industry: Information Technology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: Israel, United States, China

Investor stats

  • Total investments: 60
  • Lead/follow: no public data

Portfolio highlights

  • Creednz — Creednz is a company that provides financial data management system that involves internal financial data sets.
  • Entitle — Control access to your organizational cloud resources without creating bottlenecks or friction while creating a seamless experience for employees.
  • Tamnoon — Tamnoon develops a state-of-the-art cloud security platform to empower security teams and manage cloud risks effectively. By harnessing the power of AI combined with human expertise, the company empowers security teams and equips organizations of all sizes with exceptional cloud protection capabilities.
Show all investments...

Chartered Opus
VC Fund · Düsseldorf, Nordrhein-Westfalen, Germany · 2 investments in Israel Biotech startups

Chartered Opus offers professional market participants (clients such as asset managers) the opportunity to realise “securitised” concepts/products for their own investment or for their customers.

Show more...

Investment focus

  • Industry: Wellness, Biotechnology, Manufacturing
  • Stage:Series A
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • SolCold — We make the sun cool again - Solcold the new environment solutions
  • Trobix Bio — Trobix Bio is a company that develops and commercializes antibacterial products. It has developed platform technologies called ActiSense and GOTrap for developing high-quality products that remove the threat of antimicrobial resistance.
Show all investments...

Yozma Group
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Biotech startups

Yozma earned worldwide recognition as the founder of Israel's VC industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Series B, Seed
  • Geography: Israel, United States, Australia

Investor stats

  • Total investments: 23
  • Lead/follow: no public data

Portfolio highlights

  • OP.GG — The Best LoL Champion Builds and Player Stats by OP.GG - Learn champion builds, runes, and counters. Search Riot ID and Tagline for stats of all game modes.
  • Illumigyn — Technology that we developed, creating high-resolution digital images with superior magnification that can substantially improve diagnostic accuracy.
  • Meat.The End — MTE revolutionizes food production to create desired textures and provides a solution for food companies, by developing novel ingredients and technological solutions that enhance the texture properties of alternative protein products.
Show all investments...

VentureIsrael
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Biotech startups

Israeli Early Stage Deep Tech Fund

Show more...

Investment focus

  • Industry: Information Technology, Software, Cyber Security
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel

Investor stats

  • Total investments: 16
  • Lead/follow: no public data

Portfolio highlights

  • Wib Security — Wib is the only way to secure your APIs from development to production, with the most comprehensive full-lifecycle API Security Platform.
  • Cydome — Cydome is a disruptive cyber solution seamlessly safeguarding the maritime IoT ecosystem including guidance, sensor, control, command, communication systems and linkage to coastal infrastructures; providing end-to-end protection from the kernel level using data and network isolation; rapid, reliable and automatic threat detection and protection.
  • Cyngular Security — Cyngular Security - Cloud Autonomous Hunting, Investigation and Response Platform Helps organizations proactively prepare for and respond to cyber security incidents, ensuring maximum protection and minimum downtime.
Show all investments...

Triventures
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Biotech startups

Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B
  • Geography: United States, Israel, Ireland

Investor stats

  • Total investments: 60
  • Lead/follow: no public data

Portfolio highlights

  • Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
  • Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
  • TailorMed — Moving Mountains for Patients
Show all investments...

Fortissimo Capital
VC Fund · Rosh Ha'ayin, HaMerkaz, Israel · 2 investments in Israel Biotech startups

Fortissimo Capital is a growth equity fund that supports companies focusing on technology industries. They partner with strong management teams to invest in growth and transformation. They invest in public and private technology companies at inflection points and in special situations, where their experience and long term strategic commitment canmaximize value.It was founded in 2004 and headquartered in HaMerkaz, Israel.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Information Technology
  • Stage:Series B, Series C
  • Geography: Israel, United States, Italy

Investor stats

  • Total investments: 40
  • Lead/follow: no public data

Portfolio highlights

  • Velox — Velox develops and manufactures industrial-grade direct-to shape digital decoration solutions for the rigid container industry. Their proprietary DTS-Inkjet technology, based on uniquely formulated inks and dedicated deposition architecture, introduces an entirely new approach to digital printing that is poised to disrupt the packaging decorationmarket.Their debut product is the Velox IDS 250 – the first industrial-grade digital decorator for mass production of cylindrical containers available on the market. It delivers superior decoration quality and capabilities that outstrip analog printing solutions, while allowing a more efficient and flexible production process and a low total cost of ownership (TCO).Velox is powered by an expert team with uniquely extensive and wide-ranging experience in digital printing. It is led by veteran executives with proven success in driving company growth.
  • Equinom — Equinom is a fully integrated food-tech company, combining agricultural know-how, culinary expertise and deep technology to develop delicious, nutritious, affordable and sustainable non-GMO plant-based ingredients – from the ground up.Sustainable, plant-based proteins are key to feeding Earth’s 10B people by 2050 The plant-based food market grew27% in 2020 and is projected to reach $162B by 2030.The industry is unable to supply the full demand for food vs. feed For decades, crops have been farmed primarily for animal feed – not for human consumption. To be palatable in human food, these crops require extensive and expensive processing. . With limited processing facilities equipped for this use, the industry is on track to supply only 50% of projected demand for plant-based foods.What is Equinom doing about it? Equinom is using science and technology to develop superior ingredients naturally, at the source – in a fraction of the time typically required to breed new crops. Equinom crops are bred naturally, without genetic editing or modification, and are optimized to make meat and dairy analogues more delicious, nutritious, cost-effective and sustainable. Ingredients designed by deep tech to bring out nature’s best The company’s proprietary Manna™ technology platform uses AI to speed the development of superior, high-yield, non-GMO ingredients as nature intended – featuring the quality traits that satisfy consumer expectations. The technology also ensures biodiversity and climate resilience that are critical to ensure food security in light of climate change. What makes Equinom a compelling foodtech investment and collaborator? Working with great partners including Meatless Farm, Roquette with GoodMills Group., Equinom is recognized as a trusted developer and supplier of unrivaled ingredients. Prestigious strategic investors such as BASF and Roquette have helped position Equinom as one of the breakout Round C companies to fuel the worldwide surge in plant-based eating.
  • Beewise — Beewise offers robotic beehives that operate with minimal human intervention, by utilizing AI-powered precision robotics. The company's solution automates all beekeeping activities in order to increase yield, reduce colony loss, and eliminate the use of chemical pesticides. We are the first comprehensive solution that keeps bees alive, inspite of all the stressors and challenges they face, allowing them to thrive, pollinate, and produce honey.
Show all investments...

NFX
VC Fund · San Francisco, California, United States · 2 investments in Israel Biotech startups, 19 in the past 12 months

We are a VC firm investing in pre-seed and seed stage startups. We back exceptional Founders building market-transforming companies.

Show more...

Investment focus

  • Industry: Software, Information Technology, Marketplace
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 271
  • Lead/follow: no public data

Portfolio highlights

  • Mana.bio — Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based therapeutics and vaccines
  • Gizmo — AI quizzes that help you learn and remember anything
  • Stoke Space — STOKE Space Technologies seamlessly connecting earth and space.
Show all investments...

BRM Capital
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Biotech startups

BRM Capital is a dynamic venture capital fund investing in early stage, Israel-related software, internet infrastructure, and communication companies. Their investment focus is on the Internet, mobile and mobile applications, digital media, online services, enterprise software, and medical device sectors and they also offer flexible, streamlinedinvestment decision making.BRM headquartered in Tel Aviv, Israel enjoys a worldwide network of industry, strategic and financial experts.

Show more...

Investment focus

  • Industry: Software, Information Technology, Internet
  • Stage:Series B, Series A
  • Geography: United States, Israel

Investor stats

  • Total investments: 88
  • Lead/follow: no public data

Portfolio highlights

  • V-Wave — V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.
  • ShopperAI — AI-powered shelf monitoring using your existing security cameras
  • Exceed Talent Capital — Exceed is an innovative platform to invest, earn, engage, influence, and celebrate Talent.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Israel Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists